Select a medication above to begin.
Elfabrio (pegunigalsidase alfa-iwxj)
pegunigalsidase alfa
Black Box Warnings .
Hypersensitivity and Anaphylaxis
severe reactions including anaphylaxis have occurred; administer where appropriate medical support including cardiopulmonary resuscitation equip. available; D/C immediately and start appropriate tx if severe reaction occurs; may consider desensitization procedure in patients with severe reaction
Adult Dosing .
Dosage forms: INJ
Special Note
- [drug name clarification]
- Info: nonproprietary name = pegunigalsidase alfa-iwxj
Fabry disease
- [1 mg/kg/dose IV q2wk]
- Info: consider premed with antihistamine, antipyretic, and/or corticosteroid
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]
Peds Dosing .
Peds dosing is currently unavailable or not applicable for this drug.